Purpose Of Congress

Unfortunately, pulmonary diseases are one of the main causes of death worldwide. In our country, about 5 million people suffer from chronic lung diseases such as asthma and COPD. When diseases such as pneumonia, tuberculosis, pulmonary vascular occlusion (trombosis), air leakage in the lungs (pneumothorax), and bleeding in lungs (diseases with hemoptysis) are added to this figure, the importance of lung disorders becomes more obvious.

The COVID-19 pandemic, which began in late December 2019 in China's Wuhan region and quickly spread throughout the world, has once again demonstrated the critical nature of the lungs by severely affecting them in a large spectrum rising to respiratory failure.

In addition to this direct effect of the COVID-19 pandemic on the lungs, many chronic lung patients were forced to postpone hospital visits during the pandemic era due to the risk of contamination in health institutions, and delayed seeking treatment for their new complaints. This condition, which we refer to as the pandemic's secondary consequence, may result in many health concerns.

Turkish Thoracic Society is organizing the "Pulmonary Diseases and COVID-19 Congress for the Public" on February 26-27, 2022, in order to inform the public and patients about COVID-19 and potential respiratory problems caused by COVID-19.

With this congress, which will be aired live on the Turkish Thoracic Society's youtube channel simultaneously in English, we hope to provide health information on the topics of interests about lung diseases and COVID-19.

We are delighted to welcome you all to this complimentary congress.